Skip to main content
Have a personal or library account? Click to login
Evaluation, Diagnosis, and Classification of Pulmonary Hypertension Cover

Evaluation, Diagnosis, and Classification of Pulmonary Hypertension

Open Access
|Jul 2021

References

  1. Galiè N, McLaughlin VV, Rubin LJ, Simmoneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J. 2019 Jan 24; 53(1): 1802148. doi: 10.1183/13993003.02148-2018.
  2. Beshay S, Sahay S, Humbert M. Evaluation and management of pulmonary arterial hypertension. Respir Med. 2020 Sep; 171: 106099. doi: 10.1016/j.rmed.2020.106099.
  3. Simonneau G, Montani D, Celermajer D, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 Jan 24; 53(1): 1801913. doi: 10.1183/13993003.01913-2018.
  4. Sitbon O, Humbert M, Jaïs X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005 Jun 14; 111(23): 310511. doi: 10.1161/CIRCULATIONAHA.104.488486.
  5. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000 Nov; 162(5): 196473. doi: 10.1164/ajrccm.162.5.9912045.
  6. Brown LM, Chen H, Halpern S, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011 Jul; 140(1): 1926. doi: 10.1378/chest.10-1166. Epub 2011 Mar 10.
  7. Frost A, Badesch D, Gibbs JS, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019 Jan 24; 53(1): 1801904. doi: 10.1183/13993003.01904-2018.
  8. Vachiéry J-L, Tedford RJ, Rosenkranz S, et al. Pulmonary hypertension due to left heart disease. Eur Respir J. 2019 Jan 24; 53(1): 1801897. doi: 10.1183/13993003.01897-2018.
  9. Nathan SD, Barbera JA, Gaine SP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019 Jan 24; 53(1): 1801914. doi: 10.1183/13993003.01914-2018.
  10. Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019 Jan 24; 53(1): 1801915. doi: 10.1183/13993003.01915-2018.
  11. Sahay S, Melendres-Groves L, Pawar L, Cajigas H. Pulmonary Hypertension Care Center Network: Improving Care and Outcomes in Pulmonary Hypertension. Chest. 2017 Apr; 151(4): 74954. doi: 10.1016/j.chest.2016.10.043.
  12. Pi H, Kosanovich CM, Handen A, et al. Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center. Chest. 2020 Jul; 158(1): 33040. doi: 10.1016/j.chest.2020.01.046.
  13. Sahay S. Evaluation and classification of pulmonary arterial hypertension. J Thorac Dis. 2019 Sep; 11(Suppl 14): S1789S1799. doi: 10.21037/jtd.2019.08.54.
  14. Bossone E, Paciocco G, Iarussi D, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest. 2002 Feb; 121(2): 5138. doi: 10.1378/chest.121.2.513.
  15. Henkes IR, Gan CT, van Wolferen SA, et al. ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest. 2008 Dec; 134(6): 12501257. doi: 10.1378/chest.08-0461.
  16. Trip P, Nossent EJ, de Man FS, et al. Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013 Dec; 42(6): 157585. doi: 10.1183/09031936.00184412.
  17. Sun XG, Hansen JE, Oudiz RJ, et al. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003 Mar 19; 41(6): 102835. doi: 10.1016/s0735-1097(02)02964-9.
  18. Nathan SD, Barbera JA, Gaine SP, et al. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019 Jan 24; 53(1): 1801914. doi: 10.1183/13993003.01914-2018.
  19. Hadinnapola C, Bleda M, Haimel M, et al. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension. Circulation. 2017 Nov 21; 136(21): 202233.
  20. Sun XG, Hansen JE, Oudiz RJ, K Wasserman. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001 Jul 24; 104(4): 42935. doi: 10.1161/hc2901.093198.
  21. Oudiz RJ. The role of exercise testing in the management of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2005 Aug; 26(4): 37984. doi: 10.1055/s-2005-916152.
  22. Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019 Jan 24; 53(1): 1801915. doi: 10.1183/13993003.01915-2018.
  23. Galiè N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903975. doi: 10.1183/13993003.51032-2015.
  24. Hellenkamp K, Unsöld B, Mushemi-Blake S, et al. Echocardiographic Estimation of Mean Pulmonary Artery Pressure: A Comparison of Different Approaches to Assign the Likelihood of Pulmonary Hypertension. J Am Soc Echocardiogr. 2018 Jan; 31(1): 8998. doi: 10.1016/j.echo.2017.09.009.
  25. Magnino C, Omede P, Avenatti E, et al. Inaccuracy of Right Atrial Pressure Estimates Through Inferior Vena Cava Indices. Am J Cardiol. 2017 Nov 1; 120(9): 166773. doi: 10.1016/j.amjcard.2017.07.069.
  26. Focardi M, Cameli M, Carbone SF, et al. Traditional and innovative echocardiographic parameters for the analysis of right ventricular performance in comparison with cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015 Jan; 16(1): 4752. doi: 10.1093/ehjci/jeu156. Epub 2014 Sep 3.
  27. Kovacs G, Olschewski A, Berghold A, Olschewski H. Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J. 2012 Feb; 39(2): 31928. doi: 10.1183/09031936.00008611.
  28. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. 2013 Dec 24; 62(25 Suppl): D4250. doi: 10.1016/j.jacc.2013.10.032.
  29. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006 Dec 19; 48(12): 254652. doi: 10.1016/j.jacc.2006.07.061.
  30. Hoeper MM, Maier R, Tongers J, et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med. 1999 Aug; 160(2): 53541. doi: 10.1164/ajrccm.160.2.9811062.
  31. Montani D, Savale L, Natali D, et al. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Eur Heart J. 2010 Aug; 31(15): 1898907. doi: 10.1093/eurheartj/ehq170.
  32. Morrell NW, Aldred MA, Chung WK, et al. Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 2019 Jan 24; 53(1): 1801899. doi: 10.1183/13993003.01899-2018.
  33. Giordano J, Khung S, Duhamel A, et al. Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): Dual-energy CT experience in 31 patients. 2017 Apr; 27(4): 16311639. doi: 10.1007/s00330-016-4500-6.
  34. Leblanc M, Leveillée F, Turcotte E. Prospective evaluation of the negative predictive value of V/Q SPECT using 99mTc-Technegas. Nucl Med Commun. 2007 Aug; 28(8): 66772. doi: 10.1097/MNM.0b013e32827a8e99.
  35. Grüning T, Drake BE, Farrell SL, Nokes T. Three-year clinical experience with VQ SPECT for diagnosing pulmonary embolism: diagnostic performance. Clin Imaging. Nov-Dec 2014; 38(6): 8315. doi: 10.1016/j.clinimag.2014.04.003.
  36. Johns CS, Swift AJ, Rajaram S, et al. Lung perfusion: MRI vs. SPECT for screening in suspected chronic thromboembolic pulmonary hypertension. J Magn Reson Imaging. 2017 Dec; 46(6): 16937. doi: 10.1002/jmri.25714. Epub 2017 Apr 4.
  37. De Siqueira ME, Pozo E, Fernandes VR, et al. Characterization and clinical significance of right ventricular mechanics in pulmonary hypertension evaluated with cardiovascular magnetic resonance feature tracking. J Cardiovasc Magn Reson. 2016 Jun 16; 18(1): 39. doi: 10.1186/s12968-016-0258-x.
DOI: https://doi.org/10.14797/OCDF4453 | Journal eISSN: 1947-6108
Language: English
Page range: 86 - 91
Accepted on: Jan 7, 2021
Published on: Jul 1, 2021
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2021 Sarah Beshay, Ashrith Guha, Sandeep Sahay, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.